1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legislation

ACA Repeal: A Look At Device Procedure Impacts

 
• By Sue Darcey

A select group of legislators are working behind closed doors on a Senate bill to repeal the Affordable Care Act. It's not yet clear how close or far apart it will be from the House American Health Care Act, but here is a graphical look at what the AHCA might mean for device procedure volumes.

Capitol House

Senate Republican leadership is continuing its closed-door effort on legislation to repeal the Affordable Care Act, causing Democrats, and some Republicans, to demand more access to the procedures. As yet, it's not clear how close the Senate bill will come to the House American Health Care Act, passed last month, in terms of the estimated number of individuals to lose health insurance and, thus, the impact on device procedure volumes. (Also see "Device Tax Repeal Passes House With GOP Health-Care Bill" - Medtech Insight, 4 May, 2017.)

In the context of ACA-repeal efforts, device companies have mostly highlighted the prospect for permanent repeal of the medical device...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

US FDA Unveils Plans To Consolidate Support Services

 
• By Derrick Gingery and Sue Sutter

Commissioner Martin Makary told staff that plans are being developed to centralize HR, IT, travel and other functions, which were heavily impacted by the 1 April reduction-in-force.

A Year After Exiting The Ventilator Market, Medtronic Recalls Thousands Of Newport Devices

 
• By Brian Bossetta

After two serious injuries and one death linked to some of its ventilators, Medtronic has recalled the devices and asked customers to stop using them and find alternative means. The action comes more than a year after the company left the market.

MDUFA VI Launches With Public Meeting, Call For Comments

 
• By Elizabeth Orr

Preparations for the reauthorization of the Medical Device User Fee Amendments for 2028-2032 are underway, with the US FDA announcing a public meeting for 4 August. After negotiations with industry and other stakeholders, a draft agreement is due to Congress by 15 January 2025.